Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A multi-kinase refers to a molecule, typically an inhibitor, that targets and inhibits multiple kinase enzymes simultaneously. Kinases are enzymes responsible for transferring phosphate groups from high-energy molecules like ATP to specific substrates—a process known as phosphorylation. This modification is crucial in regulating protein function, cell signaling pathways, metabolism, growth, proliferation, and other cellular processes. Multi-kinase inhibitors are primarily used in oncology to treat cancers where multiple kinase-driven pathways contribute to disease progression or drug resistance. Examples include drugs targeting VEGFRs, PDGFRs, FGFRs, RET, and MET.
Binding to ATP-binding site or allosteric sites on kinase enzymes, preventing phosphorylation events required for downstream signaling, and disrupting multiple cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multi-Kinase.